By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

Contact Information

Website: ivericbio.com
Email: kathy.galante@ivericbio.com
Main Phone: +1 212 845-8200
Address: Five Penn Plaza
Address 2: Suite 2372
State: NY
City / Town: New York
Country: US
Postal Code: 10001

Issuer Information

Exchange: NGS
CEO: Glenn P. Sblendorio
Employees: 57
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A